Qiagen gains on report EQT nears a deal worth about €9.6 billion
FROM THE WIRE · SEEKINGALPHA.COM
[DNA sample] Qiagen (QGEN [https://seekingalpha.com/symbol/QGEN]) ADRs rose 2% after a report that private equity firm EQT AB is close to a deal to acquire the European molecular testing firm for around €9.6 billion ($10.8 billion). Qiagen’s (QGEN…
Read at the source ↗MARKET IMPACTHIGH✦ News Impact agent estimateTone: expected bullishA large private equity takeover in molecular testing can move the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01According to Bloomberg, EQT is close to acquiring Qiagen for about €9.6 billion.
- 02The offer is €46.50 per share and the board is close to approving it.
- 03An announcement could come as soon as Wednesday, but no final decision has been made.
- 04Qiagen ADRs rose 2%.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets